UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): August 15, 2012

                                TRANSBIOTEC, INC.
                                -----------------
             (Exact name of Registrant as specified in its charter)



     Delaware                       000-53316                  26-0731818
--------------------------------------------------------------------------------
(State or other jurisdiction    (Commission File No.)       (IRS Employer
  of incorporation)                                         Identification No.)

                        3030 Old Ranch Parkway, Suite 350
                              Seal Beach, CA 90740
                  -------------------------------------------
          (Address of principal executive offices, including Zip Code)


       Registrant's telephone number, including area code: (562) 280-0483



                                       N/A
                ------------------------------------------------
          (Former name or former address if changed since last report)


<PAGE>


Item 1.01.  Entry Into a Material Definitive Agreement.

Equity Line of Credit
---------------------

     On August 15, 2012, the Company  entered into an Investment  Agreement (the
"Agreement")  with Kodiak Capital Group,  LLC ("Kodiak") in order to establish a
possible source of funding for the Company.  The Agreement  establishes  what is
sometimes referred to as an equity line of credit.

     Under the Agreement,  Kodiak will provide the Company with up to $3,000,000
of  funding.  During the term of the equity  line,  the  Company  may  request a
drawdown  under the equity line by selling shares of its common stock to Kodiak,
and Kodiak will be  obligated to purchase  the shares.  However,  the Company is
under no obligation to request any drawdowns  under the equity line.  There must
be a minimum of seven  trading days between each drawdown  request.  Kodiak will
only be obligated to purchase the shares if a Registration Statement registering
the  shares  has  been  declared   effective  by  the  Securities  and  Exchange
Commission.

     The Company may request a drawdown by sending a drawdown  notice to Kodiak,
stating  the dollar  amount of the shares it will sell to Kodiak.  The  purchase
price for the shares to be sold will be equal to 75% of the lowest  closing  bid
price of the  Company's  common stock during the five days  following a drawdown
request.  Within  seven days of the  drawdown  request,  the Company  will issue
shares to Kodiak in an amount equal to the dollar amount of the drawdown divided
by the purchase price.

     There is no minimum  amount the Company can draw down at any one time.  The
maximum  amount  the  Company  can  draw  down  at any one  time is  $3,000,000.
Notwithstanding the above, in no event shall Kodiak be required to purchase that
number of  shares  which,  when  added to the  number of shares of common  stock
beneficially  owned by Kodiak,  would exceed 9.99%of the number of shares of the
Company's common stock outstanding on any closing date.

Termination of the Agreement
----------------------------

     The Agreement will be terminated:

     o    When Kodiak has purchased  $3,000,000  of the  Company's  common stock
          pursuant to the Agreement;

     o    12 months following the date that a Registration Statement registering
          the  shares  becomes   effective  with  the  Securities  and  Exchange
          Commission; or

     o    Upon written notice of the Company to Kodiak.


     The Agreement may be terminated:

     o    In the  event  that  either  party  commits a  material  breach of the
          Agreement; or

     o    Either party becomes insolvent.

                                       2

<PAGE>


General
-------

     Upon execution of the Agreement, the Company agreed to:

     o    issue Kodiak 1,500,000 shares of its common stock; and

     o    pay Kodiak a $5,000 document preparation fee.


     Pursuant to the  Agreement  each of the parties will  indemnify one another
and the respective  party's  shareholders,  officers,  directors,  employees and
agents  from and  against  any  actions  arising  from a  party's  breach of the
Agreement.


Item 9.01.    Financial Statements and Exhibits.

      Exhibit Number    Description
      --------------    -----------

      10.3              Investment Agreement

      10.4              Registration Rights Agreement


                                       3

<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date:  September 11, 2012

                                 TRANSBIOTEC, INC.


                                 By: /s/ Scott Painter
                                     --------------------------------------
                                     Scott Painter, Chief Executive Officer

                                       4


<PAGE>
[{"type": "8-K", "sequence": "1", "filename": "form8kinvestagree9-12.txt", "description": "FORM 8-K RE INVEST AGREE", "secsgml_size_bytes": 5460}]
{"company-data": {"conformed-name": "TransBiotec, Inc.", "cik": "0001425627", "assigned-sic": "2721", "irs-number": "260731818", "state-of-incorporation": "DE", "fiscal-year-end": "0112"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-53316", "film-number": "121085280"}, "business-address": {"street1": "3030 OLD RANCH PARKWAY, SUITE 350", "street2": "SUITE 350", "city": "SEAL BEACH", "state": "CA", "zip": "90740", "phone": "(562) 280-0483"}, "mail-address": {"street1": "3030 OLD RANCH PARKWAY, SUITE 350", "street2": "SUITE 350", "city": "SEAL BEACH", "state": "CA", "zip": "90740"}, "former-company": {"former-conformed-name": "IMAGINE MEDIA LTD", "date-changed": "20080130"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): August 15, 2012

                                TRANSBIOTEC, INC.
                                -----------------
             (Exact name of Registrant as specified in its charter)

     Delaware                       000-53316                  26-0731818
--------------------------------------------------------------------------------
(State or other jurisdiction    (Commission File No.)       (IRS Employer
  of incorporation)                                         Identification No.)

                        3030 Old Ranch Parkway, Suite 350
                              Seal Beach, CA 90740
                  -------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (562) 280-0483

                                       N/A
                ------------------------------------------------
          (Former name or former address if changed since last report)
Item 1.01.  Entry Into a Material Definitive Agreement.

Equity Line of Credit
---------------------

     On August 15, 2012, the Company  entered into an Investment  Agreement (the
"Agreement")  with Kodiak Capital Group,  LLC ("Kodiak") in order to establish a
possible source of funding for the Company.  The Agreement  establishes  what is
sometimes referred to as an equity line of credit.

     Under the Agreement,  Kodiak will provide the Company with up to $3,000,000
of  funding.  During the term of the equity  line,  the  Company  may  request a
drawdown  under the equity line by selling shares of its common stock to Kodiak,
and Kodiak will be  obligated to purchase  the shares.  However,  the Company is
under no obligation to request any drawdowns  under the equity line.  There must
be a minimum of seven  trading days between each drawdown  request.  Kodiak will
only be obligated to purchase the shares if a Registration Statement registering
the  shares  has  been  declared   effective  by  the  Securities  and  Exchange
Commission.

     The Company may request a drawdown by sending a drawdown  notice to Kodiak,
stating  the dollar  amount of the shares it will sell to Kodiak.  The  purchase
price for the shares to be sold will be equal to 75% of the lowest  closing  bid
price of the  Company's  common stock during the five days  following a drawdown
request.  Within  seven days of the  drawdown  request,  the Company  will issue
shares to Kodiak in an amount equal to the dollar amount of the drawdown divided
by the purchase price.

     There is no minimum  amount the Company can draw down at any one time.  The
maximum  amount  the  Company  can  draw  down  at any one  time is  $3,000,000.
Notwithstanding the above, in no event shall Kodiak be required to purchase that
number of  shares  which,  when  added to the  number of shares of common  stock
beneficially  owned by Kodiak,  would exceed 9.99%of the number of shares of the
Company's common stock outstanding on any closing date.

Termination of the Agreement
----------------------------

     The Agreement will be terminated:

     o    When Kodiak has purchased  $3,000,000  of the  Company's  common stock
          pursuant to the Agreement;

     o    12 months following the date that a Registration Statement registering
          the  shares  becomes   effective  with  the  Securities  and  Exchange
          Commission; or

     o    Upon written notice of the Company to Kodiak.

     The Agreement may be terminated:

     o    In the  event  that  either  party  commits a  material  breach of the
          Agreement; or

     o    Either party becomes insolvent.

                                       2
General
-------

     Upon execution of the Agreement, the Company agreed to:

     o    issue Kodiak 1,500,000 shares of its common stock; and

     o    pay Kodiak a $5,000 document preparation fee.

     Pursuant to the  Agreement  each of the parties will  indemnify one another
and the respective  party's  shareholders,  officers,  directors,  employees and
agents  from and  against  any  actions  arising  from a  party's  breach of the
Agreement.

Item 9.01.    Financial Statements and Exhibits.

      Exhibit Number    Description
      --------------    -----------

      10.3              Investment Agreement

      10.4              Registration Rights Agreement

                                       3
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date:  September 11, 2012

                                 TRANSBIOTEC, INC.

                                 By: /s/ Scott Painter
                                     --------------------------------------
                                     Scott Painter, Chief Executive Officer

                                       4